ArticleGut microbes reports2025
Probiotic supplementation improves well-being and anxiety in healthy women: An exploratory, randomized, double-blind, placebo-controlled study.
Article in Gut microbes reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06507111 (The Impact of Probiotic Supplementation on the Well-being of Women.), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
The Impact of Probiotic Supplementation on the Well-being of Women.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The gut microbiota plays an important role in the maintenance of health and well-being throughout the life course but little is known about the impact of these changes on the balance of the microbiota and the well-being of women during their midlife transitional phase. In this exploratory, randomized, double-blind, placebo-controlled study, women (45 to 65 years old) received either a daily dose of probiotics or placebo for 4-months. Measurements of overall well-being included anxiety, depression, quality of life and sleep quality, gastrointestinal discomfort and changes to the fecal microbiota composition(ClinicalTrials.gov: NCT06507111). The women in the probiotic group showed a 40% reduction in anxiety, an 18.5% improvement in quality of life and indications of improved sleep, resulting in a significant 17.5% improvement in overall well-being compared to those in the placebo. Incidence rates of indigestion and stomach pains were reduced and
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.